Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging.
暂无分享,去创建一个
M E Moseley | M. Moseley | G. Albers | M. Lansberg | D. Tong | M. O'Brien | G W Albers | D C Tong | M G Lansberg | M W O'Brien | M. O’Brien | Michael W. O’Brien
[1] W. Mali,et al. Diffusion-weighted magnetic resonance imaging in acute stroke. , 1998, Stroke.
[2] G. Albers,et al. Diffusion-weighted MRI for evaluation of acute stroke , 1998, Neurology.
[3] V Beaudouin,et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. , 1996, Stroke.
[4] J. Grotta. Why do all drugs work in animals but none in stroke patients? 2 Neuroprotective therapy , 1995, Journal of internal medicine.
[5] S M Davis,et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI , 1998, Neurology.
[6] H. Lutsep,et al. Clinical utility of diffusion‐weighted magnetic resonance imaging in the assessment of ischemic stroke , 1997, Annals of neurology.
[7] S. Atlas,et al. Diffusion-weighted MRI in acute subcortical infarction. , 1998, Stroke.
[8] B. Bell,et al. CBF and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in baboons. , 1985, Journal of neurosurgery.
[9] P D Lyden,et al. Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. , 1999, Stroke.
[10] G. Schlaug,et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion‐weighted magnetic resonance imaging , 1997, Annals of neurology.
[11] K Minematsu,et al. Diffusion‐weighted magnetic resonance imaging , 1992, Neurology.
[12] G. D. del Zoppo. Clinical trials in acute stroke , 1998, Neurology.
[13] K. Lees. Cerestat and other NMDA antagonists in ischemic stroke , 1997, Neurology.
[14] E. Lo,et al. Pharmacologic Reversal of Acute Changes in Diffusion-Weighted Magnetic Resonance Imaging in Focal Cerebral Ischemia , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] Gottfried Schlaug,et al. Ischemic lesion volumes in acute stroke by diffusion‐weighted magnetic resonance imaging correlate with clinical outcome , 1997, Annals of neurology.
[16] R. Ordidge,et al. Magnetic Resonance Imaging Assessment of Evolving Focal Cerebral Ischemia Comparison With Histopathology in Rats , 1994, Stroke.
[17] T. L. Davis,et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. , 1996, Radiology.
[18] M. Moseley,et al. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI , 1996, Brain Research.
[19] M. O’Brien,et al. Ischemic Cerebral Edema. A Review , 1979, Stroke.
[20] W. Koroshetz,et al. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators. , 1999, Stroke.
[21] M. E. Moseley,et al. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke , 1998, Neurology.
[22] J. Kucharczyk,et al. Early detection of regional cerebral ischemia in cats: Comparison of diffusion‐ and T2‐weighted MRI and spectroscopy , 1990, Magnetic resonance in medicine.
[23] K Wienhard,et al. Progressive Derangement of Periinfarct Viable Tissue in Ischemic Stroke , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] L H Schwamm,et al. Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. , 1998, Stroke.